Aebi Schmidt Holding AG (AEBI)
Live price chart, market sentiment, and community perspectives for Aebi Schmidt Holding AG (NASDAQ: AEBI).
Live price chart, market sentiment, and community perspectives for Aebi Schmidt Holding AG (NASDAQ: AEBI).
On our desk, we are seeing solid validation of the Shyft Group integration. The H1 2026 revenue jump to $952 million proves that management's post-merger execution is outpacing initial skepticism, giving us confidence to maintain a constructive long-term outlook despite minor intraday volume dips.
From a quant perspective, the divergence between DA Davidson raising its price target to $17 and the recent 5.3% pullback creates a classic dislocation setup. The stock is currently trading at an attractive entry point relative to its forward 2026 sales guidance range of $1.95B to $2.15B.
Looking at the Q2 numbers, the 22% increase in adjusted EBITDA to $42.1 million and a healthy order backlog of $1.28 billion provide exceptional visibility for the rest of 2026. Margin expansion from realized synergies is happening faster than our base case anticipated.
On our risk management desk, we note that total debt stands at $617.7 million against $109.7 million in cash, with leverage projected around 2x or slightly above by year-end 2026. While manageable given the expanding cash flows, debt service remains a key variable to monitor as interest rate environments shift.
Watching the 50-day moving average and recent 8-K filings, North America continues to be the standout growth engine, delivering robust net sales growth and strong segment EBITDA. Management's stated ambition of reaching $3 billion in revenue by 2030 anchors a very compelling multi-year growth narrative.
Explore plasma cleansing, somatic organ swaps, and BCI.